ATE516061T1 - Medikament zur behandlung des reizdarmsyndroms mit diarrhö - Google Patents

Medikament zur behandlung des reizdarmsyndroms mit diarrhö

Info

Publication number
ATE516061T1
ATE516061T1 AT05001928T AT05001928T ATE516061T1 AT E516061 T1 ATE516061 T1 AT E516061T1 AT 05001928 T AT05001928 T AT 05001928T AT 05001928 T AT05001928 T AT 05001928T AT E516061 T1 ATE516061 T1 AT E516061T1
Authority
AT
Austria
Prior art keywords
irgitable
diarrhea
medicine
treatment
bowel syndrome
Prior art date
Application number
AT05001928T
Other languages
English (en)
Inventor
Akito Nishida
Akira Niwa
Yutaka Atsuta
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2004/000896 external-priority patent/WO2004066998A1/ja
Priority claimed from PCT/JP2004/006657 external-priority patent/WO2005073220A1/ja
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ATE516061T1 publication Critical patent/ATE516061T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05001928T 2004-01-30 2005-01-31 Medikament zur behandlung des reizdarmsyndroms mit diarrhö ATE516061T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2004/000896 WO2004066998A1 (ja) 2003-01-31 2004-01-30 安定な経口用固形医薬組成物
PCT/JP2004/006657 WO2005073220A1 (ja) 2004-01-30 2004-05-12 下痢型過敏性腸症候群治療剤

Publications (1)

Publication Number Publication Date
ATE516061T1 true ATE516061T1 (de) 2011-07-15

Family

ID=39855141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05001928T ATE516061T1 (de) 2004-01-30 2005-01-31 Medikament zur behandlung des reizdarmsyndroms mit diarrhö

Country Status (3)

Country Link
EP (1) EP1559446B1 (de)
AT (1) ATE516061T1 (de)
PL (1) PL380448A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US6566369B2 (en) * 2000-07-26 2003-05-20 Solvay Pharmaceuticals Gmbh Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients

Also Published As

Publication number Publication date
EP1559446B1 (de) 2011-07-13
PL380448A1 (pl) 2007-02-05
HK1090561A1 (en) 2006-12-29
EP1559446A1 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DE602006019838D1 (de) Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP1981526A4 (de) Adiponectin zur behandlung verschiedener erkrankungen
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
DE602006019560D1 (de) 2-cyanobenzolsulfonamidverbindungen zur behandlung von samen
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP1991218A4 (de) Verwendung von cyclolignanen zur behandlung von diabetes typ 2 und als kontrazeptiva
EP1755661A4 (de) Verwendung von gelsolin zur behandlung von infektionen
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
EP3769718C0 (de) Vorrichtung zur behandlung von darmerkrankungen
ATE438623T1 (de) Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs
EP1937319A4 (de) System zur behandlung mit ultravioletter strahlung
ATE525355T1 (de) 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1
ATE484279T1 (de) Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
DE502005002324D1 (de) Reaktor zur behandlung hochviskoser kunststoffschmelzen
ATE501717T1 (de) Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties